| Author (Corporate) | European Commission |
|---|---|
| Series Details | COM (2019) 228 |
| Publication Date | 14/05/2019 |
| Content Type | Policy-making, Report |
|
Summary: Report presented on 14 May 2019 by the European Commission evaluating the work of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the EU Agency on drugs. Further information: The report confirms that, over the period 2013 to 2018, the Agency continued to be widely recognised as a true hub of scientific excellence in Europe and internationally, providing factual, objective, reliable and comparable data at European level on drugs, drug addiction and their consequences. This data supports evidence-based policy making on drug control at EU level, and is also widely used by international stakeholders, researchers and practitioners. The Agency is successfully monitoring emerging threats and trends, a key aspect given that drug demand and supply are part of a dynamic and constantly changing landscape. It continues to play a leading role in the early detection and monitoring of new psychoactive substances, which can cause extremely serious health and social harms, including acute intoxications and deaths. Among the areas for improvements identified in the report, the Agency could further develop its work on monitoring supply-side and poly-drug issues, increase its visibility with practitioners and the general public, and enhance its cooperation with international organisations. The report is accompanied by a Commission staff working document providing more detailed information. Background: The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993 as one of the EU’s decentralised agencies. Its objective is to provide the EU and its Member States with factual, objective, reliable and comparable information at European level on drugs, drug addiction and their consequences. The Agency’s core tasks are to collect and analyse existing data, improve data comparison methods, disseminate data and to cooperate with European and international bodies and organisations as well as with third countries. The Agency acts as a centre of excellence in providing information on the drugs phenomenon, not only in Europe but also internationally. |
|
| Source Link | Link to Main Source https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=COM:2019:228:FIN |
| Related Links |
|
| Subject Categories | Health |
| Subject Tags | Drugs |
| Keywords | European Monitoring Centre for Drugs and Drug Addiction [EMCDDA] |
| International Organisations | European Union [EU] |
